1. Overexpression of B7-H3 in α-SMA-Positive Fibroblasts Is Associated With Cancer Progression and Survival in Gastric Adenocarcinomas
    Shenghua Zhan et al, 2020, Front. Oncol. CrossRef

  2. B7-H3 Regulates Glioma Growth and Cell Invasion Through a JAK2/STAT3/Slug-Dependent Signaling Pathway


    Chuanhong Zhong et al, 2020, OTT CrossRef
  3. Potential Therapeutic Targets of B7 Family in Colorectal Cancer
    Changgang Wang et al, 2020, Front. Immunol. CrossRef
  4. B7-H3 Immune Checkpoint Protein in Human Cancer
    Karine Flem-Karlsen et al, 2020, CMC CrossRef
  5. Immune function of miR-214 and its application prospects as molecular marker
    Qiuyuan Wang et al, 2021 CrossRef
  6. Synergistic anti-tumor efficacy of oncolytic influenza viruses and B7-H3 immune- checkpoint inhibitors against IC-resistant lung cancers
    Dörthe Masemann et al, 2021, OncoImmunology CrossRef
  7. The expression of B7-H3 isoforms in newly diagnosed glioblastoma and recurrence and their functional role
    Marina Digregorio et al, 2021, acta neuropathol commun CrossRef
  8. Clinical Insights Into Novel Immune Checkpoint Inhibitors
    Jii Bum Lee et al, 2021, Front. Pharmacol. CrossRef
  9. Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics
    Jan P. Bogen et al, 2021, Front. Oncol. CrossRef
  10. CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1
    Sibel Durlanik et al, 2021, Sci Rep CrossRef
  11. B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors
    Petar Rasic et al, 2021, WJGO CrossRef
  12. Surfaceome Profiling of Rhabdomyosarcoma Reveals B7-H3 as a Mediator of Immune Evasion
    Roxane R. Lavoie et al, 2021, Cancers CrossRef
  13. Cross-Talk Between Tumor Cells Undergoing Epithelial to Mesenchymal Transition and Natural Killer Cells in Tumor Microenvironment in Colorectal Cancer
    Ana Vuletić et al, 2021, Front. Cell Dev. Biol. CrossRef
  14. Elucidating Spatially-Resolved Changes in Host Signaling During Plasmodium Liver-Stage Infection
    Elizabeth K. K. Glennon et al, 2022, Front. Cell. Infect. Microbiol. CrossRef
  15. Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy
    Peng Ding et al, 2022, Front. Immunol. CrossRef
  16. Clinical significance of B7-H3 and HER2 co-expression and therapeutic value of combination treatment in gastric cancer
    Xinxin Shao et al, 2022, International Immunopharmacology CrossRef
  17. An Open-Source AI Framework for the Analysis of Single Cells in Whole-Slide Images with a Note on CD276 in Glioblastoma
    Islam Alzoubi et al, 2022, Cancers CrossRef
  18. Dynamic changes in human THP-1-derived M1-to-M2 macrophage polarization during Thelazia callipaeda MIF induction
    Changzhu Yin et al, 2023, Front. Immunol. CrossRef
  19. Roles of cancer stem cells in cancer immune surveillance
    Nhat-Chau TRUONG et al, 2023, Minerva Biotechnol Biomol Res CrossRef
  20. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy
    Siji Chen et al, 2023, J Cancer Res Clin Oncol CrossRef
  21. A Novel Pyroptosis-Based Prognostic Model Correlated with the Parainflammatory Immune Microenvironment of Pancreatic Cancer
    Kong-kong Wei et al, 2023, Journal of Immunology Research CrossRef
  22. B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention
    Elizabeth Varghese et al, 2024, Cancer Metastasis Rev CrossRef
  23. CD276 Promotes an Inhibitory Tumor Microenvironment in Hepatocellular Carcinoma and is Associated with Poor Prognosis
    Wen-Feng Liu et al, 2024, JHC CrossRef